Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net Income/(loss)	$ (1,035,427)	$ (614,170)
Adjustments to reconcile net loss to net cash (used in) operating activities
Fair value of stock options issued	821,995	109,874
Imputed interest		76,063
Loss on shares issued for settlement of accounts payable - related party		8,685
Impairment expense	231,462
Realized gain on sale of marketable securities	(793,391)	(1,006,588)
Litigation expense	17,780
Other assets	8,222	(8,222)
Accounts payable and accrued expenses	(62,894)	11,798
Net cash (used in) operating activities:	(830,034)	(1,422,560)
Cash flows from investing activities:
Accrued interest receivable - related party		(14,194)
Cash received from sale of marketable securities	793,391	1,006,588
Cash provided from investing activities:	793,391	992,394
Net increase/(decrease) in cash and cash equivalents	(36,643)	(430,166)
Cash and cash equivalents, including restricted, beginning of year	44,421	474,587
Cash and cash equivalents, including restricted, end of period	7,778	44,421
Non-cash financing activities
Shares issued for settlement of accounts payable - related party		62,125
Gain on forgiveness of account payable - related party		14,401
Cash paid during the year for:
Interest
Income taxes